Clinical Trials Logo

Hidradenitis Suppurativa clinical trials

View clinical trials related to Hidradenitis Suppurativa.

Filter by:

NCT ID: NCT02808975 Not yet recruiting - Clinical trials for Hidradenitis Suppurativa

Safety and Efficacy of Humira (Adalimumab) for Hidradenitis Suppurativa (HS) Peri-Surgically (SHARPS Study)

SHARPS
Start date: June 2016
Phase: Phase 4
Study type: Interventional

The objective of this study is to assess the safety and efficacy of adalimumab prior to surgery in subjects with moderate to severe Hidradenitis Suppurativa (HS) who are surgical candidates.

NCT ID: NCT02786576 Not yet recruiting - Clinical trials for Hidradenitis Suppurativa

Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting

HARMONY
Start date: May 2016
Phase: N/A
Study type: Observational

This study will assess the effects of adalimumab treatment in moderate to severe Hidradenitis Suppurativa (HS) patients in the real world setting. The objectives of this study are to estimate the effectiveness of adalimumab treatment on disease severity, to estimate the impact of adalimumab treatment on patients' quality of life, psychological effect, work productivity and healthcare resource utilization and to describe treatment practices over the study period.

NCT ID: NCT02781818 Not yet recruiting - Clinical trials for Hidradenitis Suppurativa

A Randomized Controlled Trial Evaluating the Efficacy of Intralesional Triamcinolone in Hidradenitis Suppurativa.

Start date: June 2016
Phase: N/A
Study type: Interventional

Purpose: To evaluate the effectiveness of intralesional triamcinolone for the treatment of hidradenitis suppurativa Participants: Patients diagnosed with Hidradenitis Suppurativa that have active inflammatory HS lesions. Up to 50 lesions will be treated. Between 17 and 50 patients will be enrolled dependent on the number of lesions they have treated. (up to 3 per patient) Procedures (methods): Injection of triamcinolone or placebo into active lesions of hidradenitis suppurativa

NCT ID: NCT02739828 Recruiting - Clinical trials for Hidradenitis Suppurativa

Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients

HOPE
Start date: April 2016
Phase: N/A
Study type: Observational

The objective of this study is to assess quality of life (QoL), skin pain, work productivity/activity and health related problems in Swedish patients with moderate to severe HS before and after 6 months treatment with Adalimumab. The patients will be treated in accordance with normal routine clinical care.

NCT ID: NCT02695212 Not yet recruiting - Clinical trials for Hidradenitis Suppurativa

Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa

HS
Start date: March 2016
Phase: Phase 2
Study type: Interventional

The primary objective of this study is to evaluate the safety and efficacy of Apremilast in subjects with moderate Hidradenitis Suppurativa (HS).

NCT ID: NCT02643654 Recruiting - Clinical trials for Hidradenitis Suppurativa

MABp1 IN HIDRADENITIS SUPPURATIVA REFRACTORY TO ADALIMUMAB

Start date: December 2015
Phase: Phase 2
Study type: Interventional

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disorder. Although adalimumab is recently licensed for moderate to severe HS, many cases fail to respond or relapse during treatment. Favorable outcomes from a recently conducted double-blind randomized clinical study on the efficacy of anakinra, one interleukin(IL)-1alpha blocker, in hidradenitis suppurativa (HS), led to validate the efficacy of MABp1, a true human antiIL-1α antibody in these cases.

NCT ID: NCT02593604 Enrolling by invitation - Clinical trials for Hidradenitis Suppurativa

Quality of Life After Wide Surgical Excision in Patients With Hidradenitis Suppurativa

Start date: March 2015
Phase: N/A
Study type: Observational

Patients undergoing wide surgical excision of their hidradenitis suppurativa areas are asked by telephone about their quality of life by standard questionnaires (WHOQOL-BREF, DLQI, Skindex, MHF, FLQA-d) and their sexual function (FSFI, IIEF).

NCT ID: NCT02421172 Active, not recruiting - Clinical trials for Hidradenitis Suppurativa (Acne Inversa)

Efficacy, Safety, and Pharmacokinetics Study of CJM112 in Hidradenitis Suppurativa Patients

Start date: April 2015
Phase: Phase 2
Study type: Interventional

This is a randomized, double blind, multicenter study in patients with moderate to severe chronic hidradenitis suppurativa in parallel groups, to determine the efficacy and safety of multiple doses of CJM112 in comparison to placebo. The study has two periods to explore preliminary dose effects.

NCT ID: NCT02163746 Recruiting - Clinical trials for Hidradenitis Suppurativa

Study to Compare Two Treatments for Axillary Hidradenitis Suppurativa: Carbon Dioxide Laser Versus Surgical Deroofing

Start date: March 2014
Phase: N/A
Study type: Interventional

This study compares two well-known treatment options for Stage 2 hidradenitis suppurativa: carbon dioxide (CO2) laser excision versus surgical deroofing.

NCT ID: NCT01838499 Completed - Clinical trials for Hidradenitis Suppurativa

Assessment of the Safety, Tolerability and Efficacy of MEDI8968 in Subjects With Moderate to Severe Hidradenitis Suppurativa

Start date: May 2013
Phase: Phase 2
Study type: Interventional

The purpose of this study is to gain initial evidence for the safety, tolerability and efficacy of MEDI8968 for the treatment of subjects with moderate to severe hidradenitis suppurativa